ConductScience.org, home

Trial · NCT07896135

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPostural StabilityBaseline (Pre-Intervention)
Postural stability and dynamic Limits of Stability (LOS) were assessed using the ProKin System. Across three maximum-effort trials with 60-second rest intervals, the software calculated: Mediolateral Excursion Limit (%), Anteroposterior Excursion Limit (%), Overall Excursion Area (mm2), Directional Control Index, and Trunk Displacement Angle (o), with the mean of three successful trials retained for statistical analysis.
PrimaryPostural StabilityWeek 8 (Post-Intervention)
Postural stability and dynamic Limits of Stability (LOS) were assessed using the ProKin System. Across three maximum-effort trials with 60-second rest intervals, the software calculated: Mediolateral Excursion Limit (%), Anteroposterior Excursion Limit (%), Overall Excursion Area (mm2), Directional Control Index, and Trunk Displacement Angle (o), with the mean of three successful trials retained for statistical analysis.
PrimaryLower Quarter Y-Balance Test (YBT-LQ)Baseline (Pre-Intervention)
Dynamic balance was assessed using the Lower Quarter Y-Balance Test (YBT-LQ). Participants stood on one leg on the central platform and reached as far as possible with the contralateral leg in the anterior (AT), posteromedial (PM), and posterolateral (PL) directions while maintaining balance. The composite score for was calculated as: composite score (%) = \[AT + PM + PL maximal reach distances (cm)\] / \[3 × lower-limb length (cm)\] × 100.
PrimaryLower Quarter Y-Balance Test (YBT-LQ)Week 8 (Post-Intervention)
Dynamic balance was assessed using the Lower Quarter Y-Balance Test (YBT-LQ). Participants stood on one leg on the central platform and reached as far as possible with the contralateral leg in the anterior (AT), posteromedial (PM), and posterolateral (PL) directions while maintaining balance. The composite score for was calculated as: composite score (%) = \[AT + PM + PL maximal reach distances (cm)\] / \[3 × lower-limb length (cm)\] × 100.
SecondaryFunctional Gait Assessment Modified for ChildrenBaseline (Pre-Intervention)
Functional gait performance was assessed using the Functional Gait Assessment modified for Children (FGA-mC). The FGA-mC consists of 10-item assessment designed to evaluate higher-level gait performance under progressively challenging conditions. Higher scores indicate better functional gait performance.
SecondaryFunctional Gait Assessment Modified for ChildrenWeek 8 (Post-Intervention)
Functional gait performance was assessed using the Functional Gait Assessment modified for Children (FGA-mC). The FGA-mC consists of 10-item assessment designed to evaluate higher-level gait performance under progressively challenging conditions. Higher scores indicate better functional gait performance.
SecondarySingle Hop for Distance TestBaseline (Pre-Intervention)
The Single Hop for Distance Test used to assess unilateral lower-limb functional performance, including forward propulsion and landing control. Hop distance was measured to the nearest 0.5 cm from the starting line to the posterior aspect of the heel at landing. To allow standardized comparisons, absolute hop distance (cm) was normalized to leg length and demonstrated as a percentage.
SecondarySingle Hop for Distance TestWeek 8 (Post-Intervention)
The Single Hop for Distance Test used to assess unilateral lower-limb functional performance, including forward propulsion and landing control. Hop distance was measured to the nearest 0.5 cm from the starting line to the posterior aspect of the heel at landing. To allow standardized comparisons, absolute hop distance (cm) was normalized to leg length and demonstrated as a percentage.
SecondaryTimed Up and Down Stairs TestBaseline (Pre-Intervention)
Timed Up and Down Stairs Test was used to assess functional mobility. the subject was asked to stand 30 cm from the bottom of a 14-step flight of stairs (19.5-cm step height). The test score was the time in seconds from the "go" cue until the second foot returned to the bottom land
SecondaryTimed Up and Down Stairs TestWeek 8 (Post-Intervention)
Timed Up and Down Stairs Test was used to assess functional mobility. the subject was asked to stand 30 cm from the bottom of a 14-step flight of stairs (19.5-cm step height). The test score was the time in seconds from the "go" cue until the second foot returned to the bottom land
SecondaryTimed One-Legged Stance TestBaseline (Pre-Intervention)
The Timed One-Legged Stance test was used to assess single-limb static balance and postural control. Timing began when the no stance foot left the floor and stopped if the participant removed the hands from the hips, looked down, touched the floor with the contralateral foot, or otherwise lost the test position. Performance was recorded in seconds, with longer times indicating better balance ability.
SecondaryTimed One-Legged Stance TestWeek 8 (Post-Intervention)
The Timed One-Legged Stance test was used to assess single-limb static balance and postural control. Timing began when the no stance foot left the floor and stopped if the participant removed the hands from the hips, looked down, touched the floor with the contralateral foot, or otherwise lost the test position. Performance was recorded in seconds, with longer times indicating better balance ability.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07896135/registered